Our Mission

Our mission is to advance medical and biological research by providing the scientific community with standardized, high quality metabolic and physiologic phenotyping services for mouse models of diabetes, diabetic complications, obesity and related disorders.

The six MMPC Centers are housed at outstanding academic institutions, staffed by experts in state-of-the-art technology. Researchers can ship mice to one of the Centers and obtain on a fee-for-service basis a range of complex exams used to characterize mouse metabolism, blood composition including hormones, energy balance and physical activity, eating and exercise, insulin resistance, organ function, metabolic fluxes and morphology, physiology, histology and measures of diabetic complications in heart, kidney, vasculature, eye, etc. Many tests are done in living animals and are designed to elucidate subtle to complex traits that would define models of metabolic disease.

The development of transgenic technology and gene targeting protocols has resulted in numerous mouse lines with specific phenotypes and well-defined DNA structural changes. Candidate genes for diabetes, obesity and other disorders of metabolism have been identified and transgenic mice are being generated using this technology. By broadening the availability of sophisticated metabolic phenotyping, we hope to help investigators identify and study new mouse models that will lead to an improved understanding of these complex diseases.

In 2006, the MMPC formed a collaboration with the NIH-sponsored Animal Models of Diabetic Complications Consortium (AMDCC) in order to more thoroughly phenotype putative new mouse models of disease for a range of complications including cardiovascular disease, nephropathy, neuropathy, retinopathy. The MMPC is committed to improving access to existing tests, and to developing new technologies for this purpose.